Relief Therapeutics Holding AG (RLFTF)

[tcm55]

Good to see continued enrollment too from the NRX PR/new consent form data...

A randomized placebo-controlled trial of Aviptadil is underway that has enrolled more
than 130 patients. In that trial, no drug-related serious adverse effects were seen and
an independent data safety board determined that the trial should continue with a clear
possibility that a difference between RLF-100 and placebo will be seen.

Cant see if this is from the 102. July IRB date but new info and forms?